← FDA DRUG APPROVALS

FDA NDA · NDA017486

HEPARIN SODIUM

Sponsor: EPIC PHARMA LLC

APPLICATION
NDA017486
TYPE
NDA
ORIGINAL APPROVAL
1975-12-10
LATEST ACTION
1996-03-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HEPARIN SODIUMDiscontinued
HEPARIN SODIUM 20,000 UNITS/ML · INJECTABLE · INJECTION
HEPARIN SODIUMDiscontinued
HEPARIN SODIUM 5,000 UNITS/ML · INJECTABLE · INJECTION
HEPARIN SODIUMDiscontinued
HEPARIN SODIUM 40,000 UNITS/ML · INJECTABLE · INJECTION
HEPARIN SODIUMDiscontinued
HEPARIN SODIUM 10,000 UNITS/ML · INJECTABLE · INJECTION
HEPARIN SODIUMDiscontinued
HEPARIN SODIUM 1,000 UNITS/ML · INJECTABLE · INJECTION

Approval history

1996-03-27Labeling · Supplement 12AP
1996-03-27Labeling · Supplement 3AP
1996-03-27Labeling · Supplement 4AP
1988-01-25Labeling · Supplement 9AP
1980-11-13Labeling · Supplement 7AP
1978-12-06Labeling · Supplement 5AP
1975-12-10Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →